and support early-stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indications for novel Investigational New Drug (IND)ready agents or Investigational Device Exemption (IDE)ready devices for the treatment of mental disorders or AUD.